Abstract
Mycobacterium tuberculosis manages to remain latent in the human body regardless of extensive chemotherapy. Complete eradication of tuberculosis (TB) requires treatment strategies targeted against latent form of infection, in addition to the current regimen of antimycobacterials. Many in vitro and in vivo models have been proposed to imitate latent TB infection, yet none of them is able to completely mimic latent infection state of M. tuberculosis. Highly infectious nature of the pathogen requiring BSL3 facilities and its long generation time further add to complications. M. aurum has been proposed as an important model organism for high throughput screening of drugs and exhibits high genomic similarity with that of M. tuberculosis. Thus, the present study was undertaken to explore if M. aurum could be used as a surrogate organism for studies related to M. tuberculosis latent infection. M. aurum was subjected to in vitro conditions of oxygen depletion, lack of nutrients and acidic stress encountered by latent M. tuberculosis bacteria. CFU count of M. aurum cells along with any change in cell shape and size was recorded at regular intervals during the stress conditions. M. aurum cells were unable to survive for extended periods under all three conditions used in the study. Thus, our studies suggest that M. aurum is not a suitable organism to mimic M. tuberculosis persistent infection under in vitro conditions, and further studies are required on different species for the establishment of a fast growing species as a suitable model for M. tuberculosis persistent infection.
Similar content being viewed by others
References
Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K (2002) Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 4:717–731. doi:10.1046/j.1365-2958.2002.02779.x
Zhang Y (2004) Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci 9:1136–1156. doi:10.2741/1291
Amila A, Acosta A, Sarmiento ME, Suraiya S, Zafarina Z, Panneerchelvam S, Norazmi MN (2015) Sequence comparison of six human microRNAs genes between tuberculosis patients and healthy individuals. Int J Mycobacteriol 4:341–346. doi:10.1016/j.ijmyco.2015.06.009
Zumla A, Atun R, Maeurer M, Kim PS, Jean-Philippe P, Hafner R, Schito M (2012) Eliminating tuberculosis and tuberculosis–HIV co-disease in the 21st century: key perspectives, controversies, unresolved issues, and needs. J Infect Dis 205:S141–S146. doi:10.1093/infdis/jir880
Hutter B, Dick T (1998) Increased alanine dehydrogenase activity during dormancy in Mycobacterium smegmatis. FEMS Microbiol Lett 167:7–11. doi:10.1111/j.1574-6968.1998.tb13200.x
Mayuri Bagchi G, Das TK, Tyagi JS (2002) Molecular analysis of the dormancy response in Mycobacterium smegmatis: expression analysis of genes encoding the DevR–DevS two-component system, Rv3134c and chaperone alpha-crystallin homologues. FEMS Microbiol Lett 211:231–237. doi:10.1111/j.1574-6968.2002.tb11230.x
Parikka M, Hammarén MM, Harjula SKE, Halfpenny NJ, Oksanen KE, Lahtinen MJ, Pajula ET, Pesu M, Rämet M (2012) Mycobacterium marinum causes a latent infection that can be reactivated by gamma irradiation in adult zebrafish. PLoS Pathog 8:e1002944. doi:10.1371/journal.ppat.1002944
Carvalho R, de Sonneville J, Stockhammer OW, Savage NDL, Veneman WJ, Ottenhoff THM, Dirks RP, Meijer AH, Spaink HP (2011) A high throughput screen for tuberculosis progression. PLoS ONE 6:e16779. doi:10.1371/journal.pone.0016779
Archuleta RJ, Hoppes PY, Primm TP (2005) Mycobacterium avium enters a state of metabolic dormancy in response to starvation. Tuberculosis 85:147–158. doi:10.1016/j.tube.2004.09.002
Gupta A, Bhakta S, Kundu S, Gupta M, Srivastava BS, Srivastava R (2009) Fast-growing, non-infectious and intracellularly surviving drug-resistant Mycobacterium aurum: a model for high-throughput antituberculosis drug screening. J Antimicrob Chemother 64:774–781. doi:10.1093/jac/dkp279
Dick T, Lee BH, Murugasu-Oei B (1998) Oxygen depletion induced dormancy in Mycobacterium smegmatis. FEMS Microbiol Lett 163:159–164. doi:10.1111/j.1574-6968.1998.tb13040.x
Gupta A, Bhakta S (2012) An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis. J Antimicrob Chemother 67:1380–1391. doi:10.1093/jac/dks056
Gupta N, Singh BN (2008) Deciphering kas operon locus in Mycobacterium aurum and genesis of a recombinant strain for rational-based drug screening. J Appl Microbiol 105:1703–1710. doi:10.1111/j.1365-2672.2008.03888.x
Bartek IL, Woolhiser LK, Baughn AD, Basaraba RJ, Jacobs WR, Lenaerts AJ, Voskuil MI (2014) Mycobacterium tuberculosis Lsr2 is a global transcriptional regulator required for adaptation to changing oxygen levels and virulence. MBio 5:e01106–e01114. doi:10.1128/mBio.01106-14
Schreuder LJ, Parish T (2014) Mycobacterium tuberculosis DosR is required for activity of the PmbtB and PmbtI promoters under hypoxia. PLoS ONE 9:e107283. doi:10.1371/journal.pone.0107283
Loebel RO, Shorr E, Richardson HB (1933) The influence of adverse conditions upon the respiratory metabolism and growth of human tubercle bacilli. J Bacteriol 26:167–200
Cotter PD, Hill C (2003) Surviving the acid test: responses of gram-positive bacteria to low pH. Microbiol Mol Biol Rev 67:429–453. doi:10.1128/MMBR.67.3.429-453.2003
Saxena A, Mukherjee U, Kumari R, Singh P, Lal R (2014) Synthetic biology in action: developing a drug against MDR-TB. Indian J Microbiol 54:369–375. doi:10.1007/s12088-014-0498-0
Zahrt TC (2003) Molecular mechanisms regulating persistent Mycobacterium tuberculosis infection. Microbes Infect 5:159–167. doi:10.1016/S1286-4579(02)00083-7
Sajid A, Arora G, Singhal A, Kalia VC, Singh Y (2015) Protein phosphatases of pathogenic bacteria: role in physiology and virulence. Annu Rev Microbiol 69:527–547. doi:10.1146/annurev-micro-020415-111342
Koul S, Prakash J, Mishra A, Kalia VC (2015) Potential emergence of multi-quorum sensing inhibitor resistant (MQSIR) bacteria. Indian J Microbiol. doi:10.1007/s12088-015-0558-0
Silva MT, Appelberg R, Silva MN, Macedo PM (1987) In vivo killing and degradation of Mycobacterium aurum within mouse peritoneal macrophages. Infect Immun 55:2006–2016
Phelan J, Maitra A, McNerney R, Nair M, Gupta A, Coll F, Painc A, Bhakta S, Clark TC (2015) The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae. Int J Mycobacteriol 4:207–216. doi:10.1016/j.ijmyco.2015.05.001
Wayne LG, Hayes LG (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of non-replicating persistence. Infect Immun 64:2062–2069
Lim A, Eleuterio M, Hutter B, Murugasu-Oei B, Dick T (1999) Oxygen depletion-induced dormancy in Mycobacterium bovis BCG. J Bacteriol 181:2252–2256
Smeulders MJ, Keer J, Speight RA, Williams HD (1999) Adaptation of Mycobacterium smegmatis to stationary phase. J Bacteriol 181:270–283
Kim SY, Lee BS, Shin SJ, Kim HJ, Park JK (2008) Differentially expressed genes in Mycobacterium tuberculosis H37Rv under mild acidic and hypoxic conditions. J Med Microbiol 57:1473–1480. doi:10.1099/jmm.0.2008/001545-0
Voskuil MI, Visconti KC, Schoolnik GK (2004) Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis 84:218–227. doi:10.1016/j.tube.2004.02.003
Deb C, Lee CM, Dubey VS, Daniel J, Abomoelak B, Sirakova TD, Pawar S, Rogers L, Kolattukudy PE (2009) A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS ONE 4:e6077. doi:10.1371/journal.pone.0006077
Seiler P, Ulrichs T, Bandermann S, Pradl L, Jörg S, Krenn V, Morawietz L, Kaufmann SHE, Aichele P (2003) Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection. J Infect Dis 188:1326–1331. doi:10.1086/378563
Sood S, Kaur S, Shrivastava R (2015) A lacZ reporter-based strategy for rapid expression analysis and target validation of Mycobacterium tuberculosis latent infection genes. Curr Microbiol. doi:10.1007/s00284-015-942-3
O’Donnell G, Gibbons S (2007) Antibacterial activity of two canthin-6-one alkaloids from Allium neapolitanum. Phytother Res 21:653–657. doi:10.1002/ptr.2136
Kashyap VK, Gupta RK, Shrivastava R, Srivastava BS, Srivastava R, Parai MK, Singh P, Bera S, Panda G (2012) In vivo activity of thiophene-containing trisubstituted methanes against acute and persistent infection of non-tubercular Mycobacterium fortuitum in a murine infection model. J Antimicrob Chemother 67:1188–1197. doi:10.1093/jac/dkr592
Acknowledgments
Financial assistance provided by Department of Science and Technology (DST), Government of India (DST-INSPIRE Fellowship) to Mrs. Shivani Sood, is gratefully acknowledged. Authors are thankful to CDRI, Lucknow for providing the bacterial strain for study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare they have no financial/commercial conflicts of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sood, S., Yadav, A. & Shrivastava, R. Mycobacterium aurum is Unable to Survive Mycobacterium tuberculosis Latency Associated Stress Conditions: Implications as Non-suitable Model Organism. Indian J Microbiol 56, 198–204 (2016). https://doi.org/10.1007/s12088-016-0564-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12088-016-0564-x